<![CDATA[Ask Dr Vincent: Daily Dose]]>https://www.askdrvincent.com/s/daily-dosehttps://substackcdn.com/image/fetch/$s_!6zR_!,w_256,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fef6196c3-fd8a-4c44-8b99-689c1b41e4e9_792x792.pngAsk Dr Vincent: Daily Dosehttps://www.askdrvincent.com/s/daily-doseSubstackMon, 13 Apr 2026 04:00:34 GMT<![CDATA[The Weight Loss Pill Everyone's Talking About - Daily Dose 001]]>https://www.askdrvincent.com/p/the-weight-loss-pill-everyones-talkinghttps://www.askdrvincent.com/p/the-weight-loss-pill-everyones-talkingMon, 13 Apr 2026 00:27:19 GMTThe FDA just approved Foundayo (the first once-daily oral GLP-1 pill for weight loss), and the internet is going wild. But before you throw away your injection pen, there's a conversation we need to have about bioavailability. As a food scientist who has spent his career studying how the body absorbs and utilises nutrients, I can tell you that what you take and what your body actually uses are two very different things.

In today’s Daily Dose, I break down the science of first-pass metabolism, what it means for oral GLP-1s, and why asking "how much actually gets in?" is the most important question nobody in the wellness industry wants you asking.

Plus, the cheapest dementia prevention habit science has ever found, and a new AI tool that could warn you about disease outbreaks in your neighbourhood before you even feel sick.

Simple science, real news, no hype. Let's go. 🍎

***

Daily Dose is your daily hit of health, wellness & tech news; made simple. Hosted by Dr Vincent, your friendly neighbourhood scientist. Part of the Ask Dr Vincent universe on Substack.

Let’s be mates!

Get more from Dr Vincent in the Substack app
Available for iOS and Android
]]>